SIBN
SI-BONE, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$25.35
+6.65%Nov 2, 2026, 21:31 UTC
SI-BONE reported third-quarter 2026 revenue of $55.7 million, up 14.5% year over year, and a net loss of $3.6 million, or $0.08 per diluted share.
Source:Oct 19, 2026, 20:09 UTC
SI-BONE announced that it will report third-quarter 2026 financial results after market close on November 2, 2026.
Source:Sep 11, 2026, 20:14 UTC
SI-BONE, Inc. amended its lease with BIXBY SPE FINANCE 11, LLC, extending the term by one month to October 31, 2026 at a base rent of $43,696.00 per month.
Aug 3, 2026, 21:53 UTC
SI-BONE shares fell 10.29% in after-hours trading to $16.55, following a 3.89% gain during the regular session to $18.45, on August 3, 2026.
Source:Aug 3, 2026, 20:09 UTC
SI-BONE, Inc. reported financial results for the second quarter of 2026, with approximately 15% worldwide revenue growth and about a 178% increase in adjusted EBITDA, and raised its 2026 guidance.